Read the story here. Advertise at Before It's News here.
Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views
Last hour:
Last 24 hours:

Cardiol Therapeutics files application to list on the Nasdaq stock exchange

% of readers think this story is Fact. Add your two cents.

Cardiol Therapeutics Inc (TSE:CRDL) (OTCQX:CRTPF) (FSE:CT9) announced Tuesday that it has submitted an application to uplist its shares to the tech-laden Nasdaq stock exchange in the US.

In a statement, CEO David Elsley told investors that the firm sees it an “opportune time” for Cardiol to formally apply for an uplisting.

“We believe a Nasdaq listing will provide an ideal platform on which to build a leadership position in the treatment of inflammatory heart disease while elevating the company’s profile within the investment community,” Elsley said.

READ: Cardiol Therapeutics forms two new committees for its Phase II/III trial of CardiolRx in COVID-19 patients

The biotechnology firm also revealed that it had received proceeds of over $10 million from the exercise of warrants and stock options. Proceeds from the warrants and options will strengthen the firm’s balance sheet at a time when it is about to embark on a Phase II/III clinical trial program in the US. The trial is designed to investigate the cardioprotective properties of its lead drug candidate CardiolRx in 422 hospitalized COVID-19 patients with a prior history of, or risk factors for, cardiovascular disease.

CardiolRx is an ultra-pure, extra-strength cannabidiol oral formulation that is pharmaceutically produced, manufactured under cGMP, and THC-free (less than 10 ppm).

The Phase II/III trial “potentially positions the company to report on the impact of our lead drug candidate on reducing major cardiovascular outcomes during 2021,” Elsley added.

Cardiol cautioned that its listing is subject to the approval of the Nasdaq and the satisfaction of all applicable listing criteria and requirements.

If the Nasdaq listing occurs, the company’s shares would delist from the OTCQX exchange. Cardiol plans to maintain its current listing on the Toronto Stock Exchange.

Contact Angela at [email protected]

Follow her on Twitter @AHarmantas

Story by ProactiveInvestors


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Please Help Support BeforeitsNews by trying our Natural Health Products below!

Order by Phone at 888-809-8385 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Order by Phone at 888-388-7003 or online at M - F 9am to 5pm EST

Humic & Fulvic Trace Minerals Complex - Nature's most important supplement! Vivid Dreams again!

HNEX HydroNano EXtracellular Water - Improve immune system health and reduce inflammation

Ultimate Clinical Potency Curcumin - Natural pain relief, reduce inflammation and so much more.

MitoCopper - Bioavailable Copper destroys pathogens and gives you more energy. (See Blood Video)
Oxy Powder - Natural Colon Cleanser!  Cleans out toxic buildup with oxygen! 
Nascent Iodine - Promotes detoxification, mental focus and thyroid health.
Smart Meter Cover -  Reduces Smart Meter radiation by 96%!  (See Video)

Immusist Beverage Concentrate - Proprietary blend, formulated to reduce inflammation while hydrating and oxygenating the cells.

Report abuse


    Your Comments
    Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

    Load more ...




    Email this story
    Email this story

    If you really want to ban this commenter, please write down the reason:

    If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.